Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chandrasekharan Rajalekshmi Dhanya"'
Autor:
Manju Lekshmy, Chandrasekharan Rajalekshmi Dhanya, Jayashree SatheeshKumar Smrithi, Janaki Anandavallyamma Sindhurani, Jiji Joseph Vandanamthadathil, Jayakrishnan Therthala Veettil, Leelamma Anila, Vishnu Sasidharan Lathakumari, Adhira M. Nayar, Maya Madhavan
Publikováno v:
Pharmaceuticals, Vol 16, Iss 7, p 1054 (2023)
Breast and gynecologic cancers are significant global threats to women’s health and those living with the disease require lifelong physical, financial, and social support from their families, healthcare providers, and society as a whole. Cancer vac
Externí odkaz:
https://doaj.org/article/35a580629e62431ca8b71ea16bda5dc3
Autor:
Chandrasekharan Rajalekshmi Dhanya, Aswathy Shailaja, Aarcha Shanmugha Mary, Sumodan Padikkala Kandiyil, Ambili Savithri, Vishnu Sasidharan Lathakumari, Jayakrishnan Therthala Veettil, Jiji Joseph Vandanamthadathil, Maya Madhavan
Publikováno v:
Pathogens, Vol 11, Iss 7, p 800 (2022)
Pathogenic viruses with an RNA genome represent a challenge for global human health since they have the tremendous potential to develop into devastating pandemics/epidemics. The management of the recent COVID-19 pandemic was possible to a certain ext
Externí odkaz:
https://doaj.org/article/1e8a013f1c9748918eb2d91d20a41928
Publikováno v:
Chemical Biology & Drug Design. 101:1162-1180
RNA interference is a transformative approach and has great potential in the development of novel and more efficient cancer therapeutics. Immense prospects exist in the silencing of HER2 and its downstream genes which are overexpressed in many cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::917b51a6f497cb6604d3bf9ce17a444d
https://doi.org/10.1111/cbdd.14143
https://doi.org/10.1111/cbdd.14143